-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SdadvWMrtzka/d7nhGTqaqwSS1XDoAGQlBFc3W5n2q2Z1t99Sd5W0AkMJTNN1R1B PUW26UKHwDtq0ox7S+UA8g== 0001145549-06-001518.txt : 20061027 0001145549-06-001518.hdr.sgml : 20061027 20061027062134 ACCESSION NUMBER: 0001145549-06-001518 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20061027 DATE AS OF CHANGE: 20061027 GROUP MEMBERS: FULLERTON MANAGEMENT PTE LTD GROUP MEMBERS: TEMASEK LIFE SCIENCES PRIVATE LIMITED GROUP MEMBERS: V-SCIENCES INVESTMENTS PTE LTD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VICAL INC CENTRAL INDEX KEY: 0000819050 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 930948554 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-42755 FILM NUMBER: 061167192 BUSINESS ADDRESS: STREET 1: 10390 PACIFIC CENTER COURT STREET 2: . CITY: SAN DIEGO STATE: CA ZIP: 92121-4340 BUSINESS PHONE: 858-646-1100 MAIL ADDRESS: STREET 1: 10390 PACIFIC CENTER COURT STREET 2: . CITY: SAN DIEGO STATE: CA ZIP: 92121-4340 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: TEMASEK HOLDINGS (PRIVATE) LTD CENTRAL INDEX KEY: 0001021944 IRS NUMBER: 000000000 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 60B ORCHARD ROAD #06-18 TOWER 2 STREET 2: THE ATRIUM @ ORCHARD CITY: SINGAPORE STATE: U0 ZIP: 238891 BUSINESS PHONE: (65) 6828 6828 MAIL ADDRESS: STREET 1: 60B ORCHARD ROAD #06-18 TOWER 2 STREET 2: THE ATRIUM @ ORCHARD CITY: SINGAPORE STATE: U0 ZIP: 238891 FORMER COMPANY: FORMER CONFORMED NAME: TEMASEK HOLDINGS LTD DATE OF NAME CHANGE: 19960829 SC 13G 1 u92871sc13g.htm TEMASEK HOLDINGS (PRIVATE) LIMITED Temasek Holdings (Private) Limited
 

     
 
OMB APPROVAL
 
 
OMB Number: 3235-0145
 
 
Expires: February 28, 2009
 
 
Estimated average burden hours per response.....10.4
 
 
 
 
 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No.     )*

VICAL INCORPORATED
(Name of Issuer)
COMMON STOCK, $0.01 PAR VALUE
(Title of Class of Securities)
925602104
(CUSIP Number)
October 19, 2006
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     o Rule 13d-1(b)

     þ Rule 13d-1(c)

     o Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 
 


 

SCHEDULE 13G
                     
CUSIP No.
 
925602104 
     
 
     
 

 

           
1   NAMES OF REPORTING PERSONS:
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 
    TEMASEK HOLDINGS (PRIVATE) LIMITED
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

  (a)   o
  (b)   o
     
3   SEC USE ONLY:
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  REPUBLIC OF SINGAPORE
       
  5   SOLE VOTING POWER:
     
NUMBER OF  
       
SHARES 6   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY   4,980,079**
       
EACH 7   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON  
       
WITH: 8   SHARED DISPOSITIVE POWER:
     
    4,980,079**
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  4,980,079**
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
   
  16.9 % AS AT OCTOBER 19, 2006
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  HC
                           * SEE INSTRUCTIONS BEFORE FILLING OUT
** SEE ITEM 4 OF SCHEDULE

Page 2 of 9 pages


 

SCHEDULE 13G
                     
CUSIP No.
 
925602104 
     
 
     
 

 

           
1   NAMES OF REPORTING PERSONS:
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 
    FULLERTON MANAGEMENT PTE LTD
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

  (a)   o
  (b)   o
     
3   SEC USE ONLY:
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  REPUBLIC OF SINGAPORE
       
  5   SOLE VOTING POWER:
     
NUMBER OF  
       
SHARES 6   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY   4,980,079**
       
EACH 7   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON  
       
WITH: 8   SHARED DISPOSITIVE POWER:
     
    4,980,079**
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  4,980,079**
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
   
  16.9 % AS AT OCTOBER 19, 2006
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  HC
                           * SEE INSTRUCTIONS BEFORE FILLING OUT
** SEE ITEM 4 OF SCHEDULE

Page 3 of 9 pages


 

SCHEDULE 13G
                     
CUSIP No.
 
925602104 
     
 
     
 

 

           
1   NAMES OF REPORTING PERSONS:
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 
    TEMASEK LIFE SCIENCES PRIVATE LIMITED
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

  (a)   o
  (b)   o
     
3   SEC USE ONLY:
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  REPUBLIC OF SINGAPORE
       
  5   SOLE VOTING POWER:
     
NUMBER OF  
       
SHARES 6   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY   4,980,079**
       
EACH 7   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON  
       
WITH: 8   SHARED DISPOSITIVE POWER:
     
    4,980,079**
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  4,980,079**
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
   
  16.9 % AS AT OCTOBER 19, 2006
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  HC
                           * SEE INSTRUCTIONS BEFORE FILLING OUT
** SEE ITEM 4 OF SCHEDULE

Page 4 of 9 pages


 

SCHEDULE 13G
                     
CUSIP No.
 
925602104 
     
 
     
 

 

           
1   NAMES OF REPORTING PERSONS:
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 
    V-SCIENCES INVESTMENTS PTE LTD
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

  (a)   o
  (b)   o
     
3   SEC USE ONLY:
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  REPUBLIC OF SINGAPORE
       
  5   SOLE VOTING POWER:
     
NUMBER OF   4,980,079**
       
SHARES 6   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY  
       
EACH 7   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON   4,980,079**
       
WITH: 8   SHARED DISPOSITIVE POWER:
     
   
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  4,980,079**
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
   
  16.9 % AS AT OCTOBER 19, 2006
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  HC
                           * SEE INSTRUCTIONS BEFORE FILLING OUT
** SEE ITEM 4 OF SCHEDULE

Page 5 of 9 pages


 

ITEM 1(a). NAME OF ISSUER
The name of the issuer is VICAL INCORPORATED, a company organized under the laws of the State of Delaware (the “Issuer”).
ITEM 1(b). ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES
The principal executive offices of the Issuer are located at 10390 Pacific Center Court, San Diego, California 92121.
ITEM 2(a). NAME OF PERSON FILING
The persons filing this Statement are (i) Temasek Holdings (Private) Limited (“Temasek”), a company organized under the laws of the Republic of Singapore, (ii) Fullerton Management Pte Ltd, a company organized under the laws of the Republic of Singapore (“Fullerton”) and a wholly-owned subsidiary of Temasek, (iii) Temasek Life Sciences Private Limited, a company organized under the laws of the Republic of Singapore (“Temasek Life Sciences”) and a wholly-owned subsidiary of Fullerton and (iv) V-Sciences Investments Pte Ltd (“V-Sciences”), a company organized under the laws of the Republic of Singapore and a wholly-owned subsidiary of Temasek Life Sciences.
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE
The address of the principal business office of Temasek is 60B Orchard Road, #06-18 Tower 2, The Atrium@Orchard, Singapore 238891. The address of the principal business office of Fullerton is 60B Orchard Road, #06-18 Tower 2, The Atrium@Orchard, Singapore 238891. The address of the principal business office of Temasek Life Sciences is 60B Orchard Road, #06-18 Tower 2, The Atrium@Orchard, Singapore 238891. The address of the principal business office of V-Sciences is 60B Orchard Road, #06-18 Tower 2, The Atrium@Orchard, Singapore 238891.
ITEM 2(c). CITIZENSHIP
Temasek, Fullerton, Temasek Life Sciences and V-Sciences are all companies organized under the laws of the Republic of Singapore.
ITEM 2(d). TITLE OF CLASS OF SECURITIES
This information statement relates to the shares of common stock, par value $0.01 per share, of the Issuer (“Shares”).
ITEM 2(e). CUSIP NUMBER
The CUSIP number of the Shares is 925602104.
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR 13d-2(b), CHECK WHETHER THE PERSON FILING IS A:
Not applicable.
ITEM 4. OWNERSHIP
(a) Amount beneficially owned:
V-Sciences directly owns 4,980,079 Shares. As noted in Item 2(a) above, V-Sciences is wholly-owned by Temasek Life Sciences, which in turn is wholly-owned by Fullerton, which in turn is wholly-owned by Temasek and therefore Temasek Life Sciences, Fullerton and Temasek may be deemed to beneficially own the Shares directly owned by V-Sciences.
As described above, Temasek, Fullerton and Temasek Life Sciences may be deemed to beneficially own 4,980,079 Shares.
(b) Percent of class:
The Shares that may be deemed to be beneficially owned by Temasek, Fullerton and Temasek Life Sciences constitute approximately 16.9% of the Shares outstanding as at October 19, 2006.
The Shares directly owned by V-Sciences constitute approximately 16.9% of the Shares outstanding as at October 19, 2006.
(c) Number of shares as to which such person has:
With respect to the shared power to vote, or to direct the vote, and to dispose, or to direct the disposition of, the Shares please see Item 4(a) above regarding qualifications as to beneficial ownership.

Page 6 of 9 pages


 

(i) Sole power to vote or to direct the vote
V-Sciences: 4,980,079 Shares
(ii) Shared power to vote or to direct the vote
Temasek: 4,980,079 Shares; Fullerton 4,980,079 Shares; Temasek Life Sciences: 4,980,079 Shares
(iii) Sole power to dispose or to direct the disposition
V-Sciences: 4,980,079 Shares
(iv) Shared power to dispose or to direct the disposition of
Temasek: 4,980,079 Shares; Fullerton 4,980,079 Shares; Temasek Life Sciences: 4,980,079 Shares
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not applicable.
ITEM 10. CERTIFICATIONS
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Page 7 of 9 pages


 

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
TEMASEK HOLDINGS (PRIVATE) LIMITED
         
     
October 27, 2006       /s/ LENA CHIA  
    Name:   Lena Chia   
    Title:   Managing Director   
 
FULLERTON MANAGEMENT PTE LTD
         
     
October 27, 2006       /s/ LENA CHIA  
    Name:   Lena Chia   
    Title:   Director  
 
TEMASEK LIFE SCIENCES PRIVATE LIMITED
         
     
October 27, 2006       /s/ LAY KHIM TAN  
    Name:   Lay Khim Tan  
    Title:   Director  
 
V-SCIENCES INVESTMENTS PTE LTD
         
     
October 27, 2006       /s/ YI MING SYN  
    Name:   Yi Ming Syn  
    Title:   Director  

Page 8 of 9 pages


 

         
EXHIBIT 1
JOINT FILING AGREEMENT
We, the signatories of this Statement on Schedule 13G to which this Agreement is attached, hereby agree that such Statement is, and any amendments thereto filed by either of us will be, filed on behalf of each of us.
TEMASEK HOLDINGS (PRIVATE) LIMITED
         
     
October 27, 2006       /s/ LENA CHIA  
    Name:   Lena Chia   
    Title:   Managing Director   
 
FULLERTON MANAGEMENT PTE LTD
         
     
October 27, 2006       /s/ LENA CHIA  
    Name:   Lena Chia  
    Title:   Director  
 
TEMASEK LIFE SCIENCES PRIVATE LIMITED
         
     
October 27, 2006       /s/ LAY KHIM TAN  
    Name:   Lay Khim Tan  
    Title:   Director  
 
V-SCIENCES INVESTMENTS PTE LTD
         
     
October 27, 2006       /s/ YI MING SYN  
    Name:   Yi Ming Syn  
    Title:   Director  
 

Page 9 of 9 pages

-----END PRIVACY-ENHANCED MESSAGE-----